- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
8
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
8 companies
Genmab
Market Cap: DKK 81.9b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,291.50
7D
10.5%
1Y
-35.7%
ALK-Abelló
Market Cap: DKK 32.9b
Operates as an allergy solutions company in Europe, North America, and internationally.
ALK B
DKK 148.60
7D
12.7%
1Y
17.7%
Bavarian Nordic
Market Cap: DKK 11.8b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 151.65
7D
7.8%
1Y
1.8%
Strategic Partners
Market Cap: DKK 45.9m
Does not have significant operations.
STRAP
DKK 1,100.00
7D
18.3%
1Y
4.8%
BioPorto
Market Cap: DKK 672.9m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 1.48
7D
13.7%
1Y
16.2%
ChemoMetec
Market Cap: DKK 8.3b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 479.40
7D
16.4%
1Y
61.1%
Gubra
Market Cap: DKK 5.8b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 356.00
7D
-1.1%
1Y
17.1%
Zealand Pharma
Market Cap: DKK 30.0b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 424.50
7D
3.9%
1Y
-29.1%